Taking the research by Kim SY's team as an example, the siRNA they designed targeting the lncRNA GAS5 exhibited a significant inhibitory effect on HCC cell proliferation in both in vitro and in vivo experiments [18]. The gene discussed is GAS5; the disease is hepatocellular carcinoma.